Susumu Kobayashi

Author PubWeight™ 1.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer. Lung Cancer 2013 1.26